
- Pharmaceutical Technology\'s In the Lab eNewsletter-06-05-2019
- Volume 14
- Issue 6
Metrohm’s Acquisition of B&W Tek Boosts Spectroscopy Portfolio
Metrohm gains B&W Tek’s line of spectroscopy instruments as well as expertise and facilities.
The acquisition of B&W Tek, an instrumentation company specializing in photonics, laser, spectrometer, and chemometric technologies, by Metrohm, a manufacturer of high-precision analytical instruments, earlier in May 2019 boosts Metrohm’s spectroscopy portofolio. As of May 1, 2019, Metrohm USA and Metrohm Canada began selling B&W Tek mobile spectroscopy solutions.
The addition of the B&W Tek products complements Metrohm’s existing Raman and near-infrared (NIR) solutions for lab and process. The acquisition includes handheld 1064-nm Raman systems and portable Raman analyzers for laboratory and field use as well as solutions for laser-induced breakdown spectroscopy (LIBS). The B&W Tek products, which include NanoRam and NanoRam-1064, TacticID, i-Raman Prime, and QTRam, will maintain their respective branding during the transition.
In addition, Metrohm’s spectroscopy product development and manufacturing will expand with the addition of B&W Tek’s expertise and facilities. The company offers a complete line of analytical laboratory and process systems for titration, ion chromatography, electrochemistry, and spectroscopy.
Source: Metrohm
Articles in this issue
over 6 years ago
Cleaning Validation for Biologic Equipmentover 6 years ago
Automatic Pretreatment System for Cell Culture Media Analysisover 6 years ago
Portfolio of Tools to Advance Immunotherapyover 6 years ago
Knauer Offers New Separation Columns and Screening Servicesover 6 years ago
New Compound Discovered that Kills Antibiotic-Resistant Microbesover 6 years ago
FDA Publishes Guidance on Therapeutic Protein Biosimilarsover 6 years ago
NIH Awards Grants to Advance STI Vaccine Developmentover 6 years ago
Advancing Cell Therapy for Diabetesover 6 years ago
AstraZeneca, BenevolentAI Partner on AI for Drug DiscoveryNewsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.





